Valley National Bancorp
VLY · NASDAQ
Analyst ratings
buy · 11 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| July 15, 2026 | Cantor Fitzgerald | Maintains | Overweight | $17.00 |
| July 10, 2026 | Truist Securities | Maintains | Buy | $16.50 |
| July 7, 2026 | Barclays | Maintains | Equal-Weight | $15.00 |
| July 1, 2026 | JP Morgan | Maintains | Overweight | $17.50 |
| June 29, 2026 | Morgan Stanley | Maintains | Equal-Weight | $16.00 |
| June 26, 2026 | Piper Sandler | Maintains | Overweight | $16.50 |
| May 6, 2026 | Morgan Stanley | Downgrades | Equal-Weight | $15.00 |
| April 27, 2026 | TD Cowen | Maintains | Buy | $17.00 |
| April 27, 2026 | Piper Sandler | Reiterates | Overweight | $16.00 |
| April 24, 2026 | JP Morgan | Maintains | Overweight | $15.00 |
| April 24, 2026 | RBC Capital | Maintains | Outperform | $16.00 |
| April 9, 2026 | Keefe, Bruyette & Woods | Maintains | Market Perform | $14.00 |
| April 1, 2026 | JP Morgan | Maintains | Overweight | $14.50 |
| March 3, 2026 | Cantor Fitzgerald | Maintains | Overweight | $16.00 |
| March 2, 2026 | Morgan Stanley | Maintains | Overweight | $16.00 |
| January 30, 2026 | TD Cowen | Maintains | Buy | $16.00 |
| January 30, 2026 | RBC Capital | Maintains | Outperform | $14.00 |
| January 30, 2026 | Barclays | Maintains | Equal-Weight | $14.00 |
| January 30, 2026 | Keefe, Bruyette & Woods | Maintains | Market Perform | $13.00 |
| December 16, 2025 | JP Morgan | Maintains | Overweight | $14.50 |
| October 27, 2025 | TD Cowen | Maintains | Buy | $15.00 |
| October 27, 2025 | Cantor Fitzgerald | Maintains | Overweight | $15.00 |
| October 24, 2025 | Keefe, Bruyette & Woods | Maintains | Market Perform | $12.00 |
| October 24, 2025 | JP Morgan | Maintains | Overweight | $14.00 |
| October 10, 2025 | RBC Capital | Maintains | Outperform | $13.00 |
| October 1, 2025 | JP Morgan | Maintains | Overweight | $13.00 |
| September 29, 2025 | Morgan Stanley | Maintains | Overweight | $14.00 |
| September 24, 2025 | Jefferies | Upgrades | Buy | $14.00 |
| September 15, 2025 | Citigroup | Upgrades | Buy | $13.50 |
| September 12, 2025 | Truist Securities | Maintains | Buy | $13.00 |
| September 9, 2025 | Morgan Stanley | Maintains | Overweight | $13.00 |
Valuation and near-term upside potential
The stock appears undervalued relative to its Fair Value, and JP Morgan raised its price target to $17.50 with an Overweight rating, signaling meaningful upside from current levels. The stock's 66% total return over the past year and 52-week high reflect strong momentum and investor confidence in continued appreciation.
Morgan Stanley downgraded Valley National Bancorp to Equal-Weight, citing limited near-term upside potential and fewer catalysts for beating and raising guidance. Barclays also assigned only an 'equal weight' rating with a modest $15.00 price target, suggesting the stock is fairly valued after its strong run.
Balance sheet transformation and strategic execution
TD Cowen reiterated a Buy rating, highlighting the company's balance sheet transformation as a key strength. The previous capital infusion has significantly strengthened the balance sheet, facilitating a quicker transition and supporting further upside in the stock, according to Seeking Alpha analysis.
Morgan Stanley's downgrade reflects skepticism that balance sheet improvements will translate into near-term earnings catalysts. The Equal-Weight rating suggests the transformation may already be priced in, with limited scope for positive surprises or guidance raises in the coming quarters.
Earnings growth trajectory and EPS forecasts
Valley National's last quarterly results beat expectations, posting $0.29 EPS versus the $0.27 consensus. Analysts project a significant earnings ramp to $1.00 EPS for the current fiscal year and $2.00 EPS for the next, with Hovde Group and Piper Sandler both issuing outperform/overweight ratings with targets above $16.00.
Keefe, Bruyette & Woods maintained only a 'market perform' rating with a $14.00 price target, implying limited confidence in the earnings growth trajectory. The wide dispersion in analyst price targets — ranging from $14.00 to $17.50 — signals genuine uncertainty about the pace and sustainability of the projected EPS acceleration.